The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global medium chain triglycerides market grew at a CAGR of around 6% during 2015-2020. Looking forward, IMARC Group expects the market to continue its moderate growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Medium chain triglycerides (MCTs) are dietary fats with a glycerol molecule attached to three fatty acid chains. MCTs easily get absorbed and oxidized into the bloodstream, unlike other lipid molecules that require a complex digestion process. Therefore, they are being adopted for the management of several gastrointestinal disorders across the globe. They are also used to treat steatorrhea resulting from malabsorptive conditions, such as pancreatic insufficiency, prior gastrectomy and small bowel resection.
MCTs are generally administered in the form of tablets, capsules, ointments, powders and injections. A significant rise in the prevalence of gastrointestinal and malabsorptive disorders represents one of the leading factors increasing the adoption of MCTs. Apart from this, as MCTs are derived from organic and natural sources like coconut oil, palm oil and butter, they are finding applications in the cosmetics industry worldwide. Moreover, on account of their lightweight, long shelf life, and lack of color and odor, they are gaining popularity in aromatherapy. Besides this, leading players are investing in research and development (R&D) projects as MCTs show promising results in the management of obesity, cardiovascular diseases and neurological disorders. Furthermore, governing agencies of various countries, along with several healthcare groups and non-governmental organizations (NGOs), are initiating various programs and campaigns to spread awareness about various chronic diseases. This, in confluence with the growing health consciousness among individuals and the increasing prevalence of chronic and lifestyle diseases, is anticipated to promote the sales of MCTs in the pharmaceutical industry.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medium chain triglycerides market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on type, source, form and application.
Breakup by Type:
Breakup by Source:
Breakup by Form:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Barlean’s, BASF SE, ConnOils LLC, Croda International Plc, DuPont de Nemours Inc., IOI Oleo GmbH, KLK OLEO, Musim Mas Holdings, NOW Foods, Sternchemie GmbH & Co. KG, The Procter & Gamble Company and Wilmar International Limited.
|Base Year of the Analysis||2020|
|Segment Coverage||Type, Source, Form, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Barlean’s, BASF SE, ConnOils LLC, Croda International Plc, DuPont de Nemours Inc., IOI Oleo GmbH, KLK OLEO, Musim Mas Holdings, NOW Foods, Sternchemie GmbH & Co. KG, The Procter & Gamble Company and Wilmar International Limited|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at